Activation of the c-myc proto-oncogene by one of the imnunoglobulin (I
g) loci after chromosomal translocation is a consistent feature of Bur
kitt's lymphoma. Different subtypes of this tumor vary in the molecula
r architecture of the translocation region. In most cases there are no
known regulatory elements of the Ig locus neighboring the oncogene an
d this considerably obscures the mechanism of its deregulation. In ord
er to assess possible oncogene activation signals, we produced an expe
rimental translocation region by insertion of a c-myc gene about 50 kb
from the IgH intron enhancer in a yeast artificial chromosome (YAC) c
ontaining a 220 kb region of the human Ig heavy chain (IgH) locus. Sin
gle copy integration of this YAC into the genome of mouse embryonic st
em (ES) cells was achieved by spheroplast fusion. Chimeric mice derive
d from these ES cells developed monoclonal B-cell lymphomas expressing
surface IgM by 8-16 weeks of age. The IgH/c-myc translocus showed dif
ferent V(H)DJ(H) rearrangement in almost all tumors without any altera
tions of the distance between c-myc and the IgH intron enhancer. This
mouse model can be used for the in vivo analysis of c-myc deregulation
and the tumor formation capacity of the IgH locus in aberrant rearran
gements.